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We have previously reported that virulent egg yolk-grown Legionella pneumophila, 
Philadelphia 1strain, multiplies intracellularly in human blood monocytes and only 
intracellularly under tissue culture conditions (1). Because this bacterium can multiply 
extracellularly on complex media, L. pneumophila is a facultative intracellular parasite. 
Patients with Legionnaires' disease respond to the infection by producing antibody 
against L. pneumophila. In fact, the diagnosis of Legionnaires' disease is most often 
made serologically by demonstrating a rise in antibody titer to L. pneumophila during 
the course of the disease. However, the role of antibody in prevention or control of the 
disease has not been defined. 
In this study, we have examined the interaction between virulent egg yolk-grown 
L. pneumophila and human polymorphonuclear leukocytes (PMN), 1 antibody, and 
complement in vitro under antibiotic-free conditions. We shall demonstrate hat L. 
pneumophila b cteria re resistant to the bactericidal effects of serum and that hese 
bacteria, even when coated with antibody and complement, are only partially 
susceptible to killing by PMN. These findings uggest that PMN, even in conjunction 
with the humoral immune system, do not play a decisive role in defense against he 
Legionnaires' disease bacterium. 
Materials and Methods 
Media. Egg yolk buffer (EYB), EYB that contained 1% bovine serum albumin (EYB-BSA), 
Hanks' balanced salt solution (HBSS), Dulbecco's phosphate-buffered saline with Ca ++ and 
Mg +÷ ions (PBS), and RPMI  1640 medium were obtained or prepared as described previously 
(1, 2). No antibiotics were added to any medium in any of the experiments. 
Agar. Modified charcoal yeast extract agar (CYE agar) was prepared in 100- × 15-mm 
bacteriologic Petri dishes as described (1). 
Antisera. Goat ant i -human complement C3, IgG fraction, rhodamine-conjugated (N. L. 
Cappel Laboratories, Inc., Coehranville, Pa.); rabbit anti-L, pneumophila, Knoxville 1 strain, 
* Supported by grant AI 08697 from the National Institutes of Health. 
:~ This work was performed while Dr. Horwitz was a U. S. Public Health Service postdoctoral fellow 
(fellowship AI 05629). 
I Abbreviations u ed in this paper." CFU, colony-forming units; CYE agar, modified charcoal yeast extract 
agar; EYB, egg yolk buffer; EYB-BSA, egg yolk buffer that contained 1% bovine serum albumin; HBSS, 
Hanks' balanced salt solution; IFA, indirect fluorescent antibody assay; PBS, phosphate-buffered saline 
with Ca ++ and Mg +÷ ions; PMN, human polymorphonuclear leukocytes. 
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(Group 1) antiserum, globulin fraction, and fluorescein-conjugated globulins from the same lot, 
were obtained from the Center for Disease Control, U. S. Public Health Service, Atlanta, Ga. 
The nonconjugated antiserum was diluted 1:9 in PBS and dialyzed three times against 100 
volumes of PBS; 0.6 #1 of this antiserum preparation agglutinated 1 ml of a suspension of L. 
pneumophila (prepared by culturing egg yolk-grown organisms for 72 h on CYE agar and 
Suspending the bacteria in EYB at a concentration of 0.30 OD U at A~0 nm on a Coleman 44 
spectrophotometer [Perkin-Elmer Corp., Instruments Div., Norwalk, Conn.]). Consequently, 
0.6 #1 of this antiserum preparation is referred to in this paper as 1 agglutinating U. In our 
studies, we used 8.5 agglutinating U/ml;  at the concentrations of L. pneumophila (<_ 106 colony- 
forming units [CFU]/ml) used in our studies, this amount of antibody did not agglutinate the 
bacteria. 
Serum. Venous blood was obtained, clotted, and serum separated and stored at -70°C until 
used as described (2). Normal human serum with an indirect fluorescent antibody (IFA) anti- 
L. pneumophila titer of<1:64 (3) was obtained from an adult donor not known to have ever had 
Legionnaires' disease. Immune human serum with an IFA anti-L, pneumophila titer of 1:4,096 
was obtained from an adult donor who had recently recovered from Legionnaires' disease; Dr. 
John Marr of the New York City Department of Health kindly assisted in locating this person. 
Ms. Helen Kravitz of the New York City Department of Health and Dr. Karim Hechemy of 
the New York State Health Department, Albany, N. Y. determined serum IFA anti-L. 
pneumophila titers. 
Complement was inactivated by heating the serum at 56°C for 30 min just before use. 
Bacteria. L. pneumophila Philadelphia 1 strain were grown in embryonated hens' eggs, 
harvested, tested for %'iability and for the presence of contaminating bacteria, stored at -70°C,  
and partially purified by differential eentrifugation just before use, as described (1). A single 
batch was used in all experiments. 
Escherichia coli, serotype 09:K29:H-, strain Bi 161-42, an encapsulated, serum-resistant strain 
(2), was cultured and prepared for experiments as described (2). 
Human PMN. Blood from a single healthy donor (type AB +) was collected in a heparinized 
syringe and mixed h l with 0.9% sodium chloride (normal saline); PMN were separated by 
centrifugation over a discontinuous gradient of Ficoll and sodium diatrizoate by the method of 
English and Anderson (4). Residual erythrocytes were hypotonically lysed and isotonicity 
restored as described (2). PMN were resuspended in HBSS, counted, and adjusted to the 
required concentration; their viability was >99% as measured by trypan blue exclusion (2). 
The cells (>99% PMN) were used within 30 min of purification. 
Serum Bactericidal Activity for L. pneumophila. L. pneumophila n concentrations ranging from 
10 n to 10 n CFU/ml  were incubated in 0, 10, 25, or 50% fresh normal human serum in plastic 
test tubes (0.4 ml final vol) for 1 h at 37°C on a gyratory shaker at 250 rpm. In experiments in 
which serum bactericidal activity was measured in the presence of antibody, 8.5 agglutinating 
U/ml  (see above) of dialyzed rabbit anti-L, pneumophila antiserum or 20% heat-inactivated 
immune human serum was added to test tubes that contained the bacteria nd serum. At the 
end of the incubation, the contents of each tube were serially diluted in EYB-BSA and CFU of 
L. pneumophila were determined on CYE agar as described (1). 
Complement Fixation to the L. pneumophila Surface. 3 × 106 CFU ofL. pneumophila was incubated 
for 15 min at 37°C in 600/xl of medium that contained 25% fresh normal human serum, 25% 
fresh immune human serum, 25% heat-inactivated immune human serum, or 25% heat- 
inactivated immune human serum plus 25% fresh normal human serum. In some experiments, 
8.5 agglutinating U/ml  of dialyzed, noneonjugated rabbit antiserum were added instead of 
heat-inactivated immune human serum. The bacteria were then washed twice with PBS (4°C) 
and incubated with rhodamine-conjugated goat anti-human C3 IgG as described (2). The 
bacterial suspension was then air-dried on glass slides, incubated with 10/~1 of fluorescein- 
conjugated rabbit anti-L, pneumophila antiserum for 20 min at 37°C in a humidified chamber, 
washed, incubated for i0 min at 22°C in phosphate-buffered saline (pH 7.6) (5), air dried, and 
examined with a Zeiss Fluorescent Photomicroscope III (Carl Zeiss, Inc., New York). L. 
pneumophila bacteria were first identified by fluorescein fluorescence and then these bacteria 
were examined for the presence of C3 on their surfaces by rhodamine fluorescence. 
Anti-L. pneumophila antibody fixes to the surface of L. pneumophila when the bacterium is 
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incubated with antibody at 37°C for 15 min in the presence or absence of fresh normal human 
serum. This was determined by fluorescence microscopy, using fluorescein-conjugated rabbit 
anti-L, pneumophila antiserum. 
Capacity of PMN to Bind or to Ingest L. pneumophila. 5 × 106 PMN and 5 × 105 CFU of L. 
pneumophila were added to plastic tubes that contained 10% fresh normal human serum, 10% 
fresh immune human serum, or 10% heat-inactivated immune human serum. The tubes were 
brought to a final vol of 900/tl with HBSS, gassed with 5% CO2-95% air so that the pH was 
7.4, as judged by the color of the phenol red indicator dye, capped, sealed with Parafilm 
(American Can Co., Greenwich, Conn.), and incubated for 30 min at 37°C on a gyratory 
shaker at 250 rpm. At the end of the incubation, the tubes were placed in an ice-water bath to 
stop the reaction, and the cells were centrifuged onto glass slides using a sealed cytocentrifuge 
specimen container especially designed for use with biohazardous material (Cytospin and 
Accessories, Shandron Southern Instruments, Inc., Sewickley, Pa.). The cells were fixed with 
Diff-Quick Fixative (Harleco, American Hospital Supply Corp., Gibbstown, N. J.), stained 
with fluorescein-conjugated rabbit anti-L, pneumophila antiserum as described (1), and examined 
by fluorescence microscopy. The percentage of 200 consecutive PMN with associated bacteria, 
and the average number of bacter ia/PMN were determined. 
For electron microscopy, PMN and bacteria were incubated together at the same ratio and 
under the same conditions as described above. The cells were fixed and processed for electron 
microscopy essentially as described (1) except that they were centrifuged into 2% agarose before 
dehydration and embedding. The sections were stained with lead citrate and uranyl acetate (1) 
and examined with a Philips 300 electron microscope (Philips Electronic Instruments, Inc., 
Mahwah, N. J.). 
PMN-killing Assay. In all killing assays, reactants (total vol 900 p.l) were added sequentially 
to plastic tubes. The tubes were gassed with 5% CO2-95% air (final pH of contents of each tube 
-- 7.4), sealed, and incubated for 1, 2, or 3 h as described above under capacity of PMN to bind 
or ingest L. pneumophila. L. pneumophila (2.5 × 10 s or 5 X 10 s CFU) and/or E. coli (5 × 10 s CFU) 
in 100 p,I HBSS, the serum preparation (90 #1 fresh normal human serum, 90 #! fresh immune 
human serum, 90 #1 heat-inactivated immune human serum plus 90 #1 fresh normal human 
serum, or 4.5 #1 of dialyzed rabbit anti-L, pneumophila antiserum [8.5 agglutinating U/ml]  plus 
90 #1 fresh normal human serum) and enough PBS to bring the vol to 400 #1 were added first 
and incubated 10 min at 22°C. Then 2.5 or 5 X 106 PMN in 500 p,l HBSS (or the sonicate from 
an equivalent number of PMN or HBSS alone as controls) were added to each tube, after 
which the tubes were gassed, sealed, and incubated. A separate tube was used for each 
measurement; thus tubes were not opened until the end of the incubation. At that time, the 
tubes were placed in an ice-water bath to stop the reaction, and the contents were sonicated 
under sterile conditions for 15 sec continuously with a micro-tip attached to a sonicator (Heat- 
Systems Ultrasonics, Inc., Plainview, N. Y.) set at the 3 position; this amount of energy was 
sufficient o lyse the PMN completely but did not reduce bacterial CFU (1, 2). The CFU of L. 
pneumophila on CYE agar and ofE. coli on tryptic soy broth agar or CYE agar were determined 
as described (1, 2); E. coli grew equally well on both nutrient agars, but L. pneumophila grew 
only on CYE agar. 
Separation of PMN-associated and Nonassociated L. pneumophila byDifferential Centrifugation. PMN 
and L. pneumophila were incubated with normal human serum or immune human serum as 
described above under PMN-kill ing assay. At the end of the incubation, 9.1 ml of PBS (4°C) 
was added to each tube, and the contents transferred to a conical centrifuge tube and 
centrifuged at 45 g for 10 rain at 4°C. When PMN were mixed with L. pneumophila at 4°C in 
medium that contained normal human serum and centrifuged under these conditions, >99% 
of PMN were pelleted but >99% of L. pneumophila remained in the supernate. The supernate 
was removed and the pellet was resuspended in 2 ml PBS. The supernate and resuspended 
pellet were then sonicated as described above under PMN-killing assay and the total CFU in 
the pellet and supernatant fractions determined. Three replicate tubes were used for each 
measurement with immune serum and two replicate tubes for each measurement with normal 
serum. Additional replicate tubes, the contents of which were not fractionated after the 
incubation, were used to measure killing ofL. pneumophila asin the PMN-kill ing assay described 
above; two tubes were used for each measurement. 
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Results 
L. pneumophita Is Resistant to the Bactericidal Effects of Serum Even in the Presence of High 
Concentrations of Antibody. We incubated 103-106 CFU/ml  L. pneumophila n medium 
that contained various concentrations of fresh normal human serum (lacking antibody 
to L. pneumophila by the IFA assay) for 1 h at 37°C on a gyratory shaker. There was 
no reduction in CFU of L. pneumophila (Table I A). Similarly, when we incubated L. 
pneumophila n medium that contained 0-50% fresh normal human serum and either 
8.5 agglutinating U /ml  of rabbit anti-L, pneumophila antiserum (Table I B) or 20% 
heat-inactivated immune human serum (Table I C), the CFU of L. pneumophila were 
not reduced. The fresh normal human serum used in these experiments reduced CFU 
of a serum-sensitive strain of Neisseria gonorrhea by >4 logs. 
Thus, virulent egg yolk-grown L. pneumophila are resistant to the bactericidal effects 
of human serum even in the presence of high concentrations of rabbit or human anti- 
L. pneumophila antibody. 
Antibody Is Required to Fix Complement to he Surface of L. pneumophila. To determine 
whether anti-L, pneumophila antibody is required to fix complement to the surface of 
L. pneumophila, we incubated these bacteria with fresh normal human serum (a source 
of complement) in the presence and absence of heat-inactivated human or rabbit 
immune serum (sources of anti-L, pneumophila antibody) or with fresh immune human 
serum. We assayed complement fixation to the bacterial surface by fluorescence 
microscopy, using rhodamine-conjugated goat anti-human C3 IgG to visualize this 
complement component. To facilitate identification of all the bacteria, we then 
incubated the bacteria with fluorescein-conjugated rabbit anti-L, pneumophila antise- 
rum. 
Over 90% of L. pneumophila bacteria fixed C3 to their surfaces, as evidenced by 
rhodamine fluorescence, after incubation with a source of both antibody and comple- 
ment. None of the L. pneumophila exhibited rhodamine fluorescence after incubation 
with antibody or complement alone. However, the intensity of fluorescence exhibited 
by L. pneumophila after incubation with high-titer specific antibody (human or rabbit) 
and complement was weak in comparison to that exhibited by a serum-resistant 
encapsulated strain of E. coli (E. coli 09:K29:H-) (2). This suggests that the anti-L. 
pneumophila antibodies found in human immune serum or in rabbit antiserum are not 
capable of fixing as much C3 to the surface of L. pneumophila as human anti-E, coli 
antibodies are capable of fixing to the surface of the E. coli strain. 
PMN Phagocytose L. pneumophila Only in the Presence of Both Antibody and 
Complement. We incubated PMN with L. pneumophila n the presence of serum that 
contained anti-L, pneumophila antibody and/or complement. We then centrifuged the 
PMN onto glass slides, stained the PMN-associated bacteria with fluorescein-conju- 
gated rabbit anti-L, pneumophila antiserum, and examined them by fluorescence 
microscopy (Table II). 
With complement alone or antibody alone, few PMN (21 and 14%, respectively) 
bound or ingested L. pneumophila, and those that did had an average of less than two 
bacter ia/PMN (Table II). With both antibody and complement, 93.5% of PMN 
bound or ingested L. pneumophila; these had an average of 5.1 L. pneumophila/PMN 
(Table II and Fig. 1 A). 
In these experiments, the ratio of bacterial eells:PMN was ~5:1. (The CFU:PMN 
ratio was 1:10, but there are ~50 nonviable bacterial cells for each viable one [CFU] 
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TABLE I 
Viability of L. pneumophila in the Pr sence of Human Serum and Rabbit or 
Human Anti-L. pneumophila Antibody 
(A) Viability in the presence of fresh normal human serum 
Initial number of 
L. pneumophila 
Number ofL. pneumophila after a 1-h incubation in 
medium that contained 0-50% serum 
0% 10% 25% 50% 
CFU/ml CFU/ml 
4.0 X 106 3.4 × 105 3.8 × 106 4.9 x 106 5.6 X 106 
3.2 X 105 3.6 × 105 6.3 × 105 6.1 × 105 3.8 × 105 
4.7 X 104 1.6 X 104 5.6 X 104 5.8 × 104 6.3 × t04 
1.3 × 103 1.7 × 103 2.5 × 10 a 3.1 × 103 3.1 × 103 
(B) Viability in the presence of fresh normal human serum and rabbit anti- 
L. pneumophila antiserum 
Number of L. pneumophila after a l-h incubation in 
medium that contained 0-50% serum and 8.5 aggluti- 
Initial number of 
L. pneumophila nating doses/ml anti-L, pneumophila antiserum 
0% 10% 25% 50% 
CFU/ml CFU/ml 
1.0 x 105 1.2 x 106 0.9 x [05 2.6 × 105 5.4 × 105 
1.1 × 104 0.6 × 104 3.6 × I04 2.8 × 104 4.2 × 104 
1.8 × 10 3 0.9 X 10 3 1.2 × tO 3 2.6 × 10 3 2.1 × IO s 
4.6 × I0 2 1.6 × lO 2 3.4 × I0 2 5.6 X 10 2 4.0 × lO z 
(C) Viability in the presence of fresh normal human serum and heat- 
inactivated immune human serum 
Initial number of 
L. pneumophila 
Number of L. pneumophila after a 1-h incubation in 
medium that contained 0-50% serum and 20% heat- 
inactivated immune human serum 
0% 10% 25% 50% 
CFU/ml CFU/ml 
2.7 × 106 2.7 × 10 ° 2.4 × 106 3.0 × 106 2.1 × l06 
3.2 × 10 ~ 3.1 × 10" 2.8 x 105 3.5 X 105 2.9 × 105 
2.7 × 104 3.6 × 104 3.1 × 104 3.4 × 104 3.1 × 104 
2.8 × 103 3.1 x 103 2.8 X 103 3.0 x 103 2.8 × 10 a 
L. pneumophila at the indicated concentrations of CFU/ml  were incubated for 
1 h at 37°C on a gyratory shaker in medium that contained 0, 10, 25, or 50% 
fresh normal human serum anc'l (A) No antibody, (B) 8.5 agglutinating doses/ 
ml of dialyzed rabbit anti-L, pneumophila antiserum, or (C) 20% heat-inactivated 
immune human serum with an IFA anti-L, pneumophila titer of 1:4,096. CFU 
were determined initially and at the end of the incubation. 
in  egg  yo lk -grown cu l tu res  [6]). That  PMN bound or  ingested  an  average  o f  4 .75 
bacter ia l  cel ls  in the  presence  o f  ant ibody  and  complement  (Tab le  II) ind icates  that  
near ly  al l  the  bacter ia l  cel ls in  the  cu l tu re  were  bound to or  ingested  by  PMN under  
these  cond i t ions .  That  th i s  conc lus ion  i  va l id  for  v iab le  bacter ia  is suppor ted  by  our  
f ind ing  (Fig. 4 B) that  near ly  al l  the  v iab le  L. pneumophila in the  cu l tu re  a re  bound to 
or  ingested  by  PMN in the  presence  o f  ant ibody  and  complement .  
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TABLE II 




Percentage of Average num- 
ber of L. pneu- Index of PMN- 
PMN binding or mophila/PMN L. pneumophila 
ingesting L.pneu- with ~1 associ- association* 
mophila ated bacteria 
Normal serum 21 1.2 25 
Heat-inactivated 14 1.8 25 
immune serum 
Fresh immune serum 93.5 5.1 475 
5 X l0 s PMN and 5 × 105 CFU of L. pneumophila (~2.5 X 107 bacterial particles) 
were incubated in the presence of 10% of the indicated serum preparation for 30 
rain at 37°C on a gyratory shaker. At the end of the incubation, the cells were 
cytocentrifuged on to glass slides, fixed, stained with fluorescein-conjugated rabbit 
anti-L, pneumophila antiserum, examined by fluorescence microscopy, and 20 consec- 
utive PMN counted. 
* The index of PMN-L. pneumophila association is the percentage of PMN with bound 
or ingested L. pneumophila multiplied by the average number ofL. pneumophila/PMN 
with ~ 1 associated bacteria. 
To determine whether PMN phagocytosed L. pneumophila when incubated with 
them in the presence of ant ibody and complement, we examined the cells by electron 
microscopy. We found 25 PMN-associated L. pneumophila upon examination of ~200 
leukocyte profiles. Of  these, 23 were intracellular (Fig. 1 B and C) and 2 were adhered 
to the surface of PMN (and appeared fixed in the process of being ingested). This 
indicates that in preparations of PMN incubated with L. pneumophila n the presence 
of both ant ibody and complement (Table II), most of the PMN-associated bacteria 
were intracellular. 
These results and our f inding that antibody was required to fix complement to L. 
pneumophila, indicate that PMN effectively phagocytose L. pneumophila only if comple- 
ment is fixed to the bacterial surface. 
PMN Require Both Antibody and Complement to Kill Any L. pneumophila. We incubated 
PMN with L. pneumophila in the presence of fresh normal human serum, heat- 
inactivated immune human serum (data not shown), or fresh immune human serum 
(Fig. 2). PMN killed L. pneumophila only when both a source of ant ibody and of 
complement were present (Fig. 2). Even then, PMN reduced CFU of L. pneumophila 
by only 0.5 log (70%) (five experiments). Increasing the ratio of PMN:L. pneumophila 
from 10:1 to 20:1 or to 40:1 or the percentage of immune human serum from 10 to 
20% or 40% did not improve PMN killing of L. pneumophila. Most of the killing 
occurred in the 1st h of incubation (Fig. 4 B). Some additional killing occurred when 
the incubation was extended from 1 to 4 h (Fig. 4B), but no addit ional killing 
occurred when the incubation was further extended from 4 to 6 h (data not shown). 
L. pneumophila Resists Killing by PMN under Conditions in Which PMN Effectively Kill a 
Serum-resistant E capsulated Strain orE. coli. To compare PMN killing of L. pneumophila 
with PMN killing of a serum-resistant encapsulated strain of E. coli, we incubated 
PMN with E. coli alone, L. pneumophila alone, or both types of bacteria in the presence 
of fresh normal human serum with or without a source of rabbit or human anti-L. 
pneumophila antibody (Fig. 3). In the experiment described in Fig. 3, we used rabbit 
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FIG. 1. PMN bind and ingest L. pneumophila in the presence of antibody and complement. (A) 
PMN bind opsonized L. pneumophila. PMN were incubated with L. pneumophila in the presence of 
fresh immune human serum for 30 min at 37°(3 on a gyratory shaker and centrifuged onto glass 
slides. The PMN-associated bacteria were stained with fluorescein-conjugated rabbit anti-L, pneu- 
mophila ntiserum and the cells were examined by fluorescence microscopy. × 1,400. (B) and (C) 
PMN ingest opsonized L. Oneumophila. PMN and L. pneumophila were incubated as in A, fixed in 
glutaraldehyde and osmium, and processed for electron microscopy. (B) PMN with three intracel- 
lular L. pneumophila b cteria (arrows). (× 11,580). (3. The bacterium at the lower portion of the 
PMN shown in B is seen at higher magnification tobe enclosed within a membrane-bound vacuole 
X 41,690. 
ant iserum, but  we obta ined simi lar results when we used immune human serum. In 
the presence of  fresh normal  serum and ant ibody,  PMN failed to kill L. pneumophila 
effectively. Under  these same condit ions, PMN reduced CFU of  E. coli by 2.5 logs. 
(PMN require both ant ibody and complement  o kill E. coli [2]; both are present in 
fresh normal  human serum, which contains low levels of  natura l  ant ibody against this 
strain of  E. coli [2].) When the E. coli and L. pneumophila were mixed together  in the 
same test tube, PMN kil led the E. coli as effectively as when the E. coli were present 
alone, ind icat ing that  the ki l l ing capaci ty  of  PMN was not reduced in cultures 
conta in ing L. pneumophila. 
L. pneumophila Resists PMN Killing Even after the Bacteria are PMN-associated. When 
PMN are incubated with L. pneumophila in the presence of  ant ibody and complement ,  
they b ind or ingest near ly all the bacter ia l  cells (Table II); however,  most of  the 
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Fla. 2. PMN require both antibody and complement to kill any L. pneumophila. PMN (5 X l0 s) 
and 2.5 X 10 s CFU of L. pneumophila were incubated at 37°C in 5% CO2-95% air on a ~ratory  
shaker for 2 h in 0.9 ml medium (final volume) containing 10% fresh normal human serum (with an 
[FA anti-L, pneumophila titer of <1:64) or 10% fresh immune human serum (with an [FA anti-L. 
pneumophila tlter of 1:4,096). In some tubes, the sonicates from 5 X l0 s PMN or buffer were added 
as controls for intact PMN. CFU in each tube were determined initially and at the end of the 
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Fio. 3. L. pneumophila resists killing by PMN under conditions in which PMN effectively kill a 
serum-resistant encapsulated strain of E. coli. PMN (2.5 × l0 n) and 5 × l0 b CFU of L. pneumophila 
and/or E. coli were incubated at 37°C for 1 h on a gyratory shaker in 0.9 ml medium (final volume) 
containing 10% fresh normal human serum (NS) alone or 10% NS plus 8.5 agglutinating units/ml 
of dialyzed rabbit anti-L, pneumophila antiserum (Aha-L.p.). CFU of E. coil and L. pneumophila were 
determined initially and at the end of the incubation. 
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bacterial cells from egg yolk-grown cultures are nonviable (6). Thus, from the studies 
described in Table II, we did not know whether PMN, in the presence of antibody 
and complement, bind or ingest that small minority of bacterial cells that are viable. 
We undertook this study to clarify this issue, and to determine whether the resistance 
ofopsonized L. pneumophila to PMN killing is a result of a failure of PMN to bind the 
viable bacteria or of a failure of PMN to kill these bacteria after binding them. We 
incubated PMN with L. pneumophila for varying periods of time, separated PMN- 
associated and nonassociated L. pneumophila by differential centrifugation, and deter- 
mined the number of CFU in each fraction. 
When we incubated PMN and L. pneumophila together in the presence of both 
antibody and complement (fresh immune human serum) (Fig. 4B), PMN killed a 
1°71 /~, Normol serum 
/ 
~1 ,Sn~ of PMN ossociated 
10'1 . jo nonossocotea 
~ Nonossocioted 
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FIc. 4. Failure of PMN to kill L. pneumophila effectively: (A) In the absence of antibody, PMN fail 
to bind L. pneumophila and, subsequently, to kill the bacteria. (B) In the presence of antibody, PMN 
rapidly bind L. pneumophila but nevertheless fail to kill a large proportion of the bacteria. PMN (5 
X 106) were incubated in plastic tubes with 5 X l0 s CFU of L. pneumophila n 0.9 ml media (final 
vol) that contained 10% fresh normal human serum (A) or 10% fresh immune human serum (B) at 
37°C in 5% CO2-95% air on a gyratory shaker for 0, l, 2, or 4 h. (in the experiment depicted in (B) 
one set of control tubes [dashed line] contained normal serum instead of immune serum.) At each 
time point, the contents of some replicate tubes were immediately assayed for the total number of 
CFU in each tube after lysing the PMN by sonication (Unfractionated samples). The contents of 
other replicate tubes were first centrifuged to separate PMN-associated and nonassociated L. 
pneumophila, asdescribed in Materials and Methods; each of these fractions was then sonicated and 
assayed for the total number of PMN-associated CFU and nonassociated CFU of L. pneumophila. 
The points on the lines labeled Sum of PMN-associated and nonassociated are th mathematical 
sums of the experimentally determined values for PMN-associated and nonassociated GFU of L. 
pneumophila ateach time point. Each point on the lines labeled Unfractionated represents he average 
for two replicate tubes ± SE. Each point on the lines labeled PMN-associated and nonassociated 
represents he average for three replicate tubes + SE. 
 o
n






Published February 1, 1981
MARCUS A. HORWITZ AND SAMUEL C. SILVERSTEIN 395 
limited proportion of the L. pneumophila and most (>75%) of the surviving bacteria 
were PMN-associated after 1 h of incubation. The additional reduction in CFU of L. 
pneumophila that occurred between 1 and 4 h after the start of the incubation appeared 
to result primarily from the death of PMN-associated bacteria. Thus, the resistance 
of opsonized L. pneumophila to PMN killing was a result of the failure of PMN to kill 
bacteria that were associated with them. 
In contrast, when we incubated PMN and L. pneumophila together in the presence 
of only complement (fresh normal human serum) (Fig. 4 A), nearly all (93%) of the 
CFU of L. pneumophila f iled to associate with PMN and, as expected from previous 
results (Fig. 2), PMN did not kill L. pneumophila under these conditions. Thus, the 
complete resistance of L. pneumophila to PMN killing in the absence of antibody was 
a result of a failure of PMN to bind these unopsonized bacteria. 
PMN Do Not Support the Growth of L. pneumophila. To determine whether PMN, like 
monocytes, upport the growth of L. pneumophila (1, 7), we incubated L. pneumophila 
with PMN in the presence of normal or immune serum on a gyratory shaker for 1 h, 
and without shaking thereafter, and determined CFU daily. L. pneumophila failed to 
multiply under either of these conditions. 
Because PMN are relatively short-lived in comparison to monocytes, we repeated 
the experiment just described except we added fresh PMN and either normal or 
immune human serum to the cultures daily. After adding fresh cells and serum, we 
incubated the cultures on a gyratory shaker for 1 h and then returned them to 
stationary incubation for the remainder of the day. L. pneurnophila did not multiply 
under these conditions either. 
Discussion 
Our experiments show that virulent egg yolk-grown L. pneurnophila are completely 
resistant o the bactericidal effects of human serum even in the presence of high-titer 
rabbit or human anti-L, pneumophila antibody. In contrast, agar-adapted L. pneumophila 
have been reported to be sensitive to serum (8). Egg yolk-grown and agar-adapted 
bacteria differ in that agar-adapted bacteria are avirulent for guinea pigs and eggs, 
whereas egg yolk-grown bacteria cause lethal infections in both. In their virulence, 
egg yolk-grown L. pneumophila more closely resemble a human pathogen than do agar- 
adapted bacteria. Consequently, we suggest that L. pneumophila that are pathogenic 
for man are also serum resistant. 
Antibody is required to fix complement to L. pneumophila and only complement- 
coated bacteria are efficiently bound to or ingested by PMN. In this respect, L. 
pneurnophila resembles encapsulated E. coli, an extracellular pathogen (2). The similar- 
ity ends here, however, because complement-coated E. coli are efficiently killed by 
PMN but complemented-coated L. pneumophila are not. A significant proportion of L. 
pneumophila resist killing by PMN even after the bacteria are bound to the PMN 
surface by phagocytosis-promoting l gands. 
The capacity of L. pneumophila to resist completely killing by human serum and 
PMN in the absence of antibody likely contributes to its pathogenicity for man. 
Because L. pneumophila are completely resistant o serum even in the presence of 
antibody, the degree to which antibody influences pathogenicity probably depends 
on how antibody affects the interaction of L. pneumophila with PMN and monocytes. 
In the case of PMN, the outcome of this interaction is inconclusive; some L. pneumophila 
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are killed but a significant proportion survive the encounter. Consequently, the critical 
questions regarding the influence of antibody on pathogenicity may be whether 
antibody influences the interaction of L. pneumophila with monocytes and, especially, 
whether antibody alters the capacity of L. pneumophila to multiply within monocytes. 
These questions are addressed in an accompanying paper (7). 
Summary  
We have previously reported that virulent egg yolk-grown Legionella pneumophila, 
Philadelphia 1 strain, multiplies intracellularly in human blood monocytes. We now 
report on the interaction between virulent L. pneumophila and human polymorpho- 
nuclear leukocytes (PMN), antibody, and complement, in vitro, under antibiotic-free 
conditions. 
L. pneumophila in concentrations ranging from 103 to 106 colony forming units 
(CFU)/ml are completely resistant o the bactericidal effects of 0-50% fresh normal 
human serum, even in the presence of high concentrations of rabbit or human anti-L. 
pneumophila antibody. 
L. pneumophila bacteria fix the third component of complement (C3) to their 
surfaces, as measured by fluorescence microscopy using rhodamine-conjugated goat 
anti-human C3 IgG, only when the bacteria re incubated with both specific anti-L. 
pneumophila antibody and complement. Similarly, L. pneumophila adhere to PMN, as 
measured by fluorescence microscopy, only in the presence of both specific antibody 
and complement. Electron microscopy revealed that these opsonized bacteria are 
phagocytosed by the PMN. 
PMN require both antibody and complement to kill L. pneumophila; even then, 
PMN reduced CFU of L. pneumophila by only 0.5 log under conditions in which they 
reduce CFU of a serum-resistant encapsulated strain of Escherichia coli by 2.5 logs. 
Separation of PMN-associated and nonassociated CFU of L. pneumophila revealed that 
the major proportion of the surviving bacteria are PMN associated. Thus, the 
ineffective killing of opsonized L. pneumophila s a result of a failure of PMN to kill 
these bacteria fter they become PMN-associated. With or without antibody, PMN 
do not support he growth of L. pneumophila. 
These findings suggest hat PMN, even in conjunction with the humoral immune 
system, do not play a decisive role in defense against the Legionnaires' disease 
bacterium. 
We thank Ms. Darragh Kelvie for excellent echnical assistance, and Ms. Judy Adams for 
preparing the electron microscopy specimens and printing the photographs in this paper. 
Received for publication 16 October 1980. 
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